Rogasch Julian M M, Furth Christian, Bluemel Stephanie, Radojewski Piotr, Amthauer Holger, Hofheinz Frank
Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.
Institute for Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
EJNMMI Res. 2020 Nov 2;10(1):134. doi: 10.1186/s13550-020-00725-y.
Asphericity (ASP) of the primary tumor's metabolic tumor volume (MTV) in FDG-PET/CT is independently predictive for survival in patients with non-small cell lung cancer (NSCLC). However, comparability between PET systems may be limited. Therefore, reproducibility of ASP was evaluated at varying image reconstruction and acquisition times to assess feasibility of ASP assessment in multicenter studies.
This is a retrospective study of 50 patients with NSCLC (female 20; median age 69 years) undergoing pretherapeutic FDG-PET/CT (median 3.7 MBq/kg; 180 s/bed position). Reconstruction used OSEM with TOF (iterations 4; subsets 16; in-plane filter 2.0, 6.4 or 9.5 mm), TOF (4 it; 8 ss; filter 2.0/6.0/9.5 mm), PSF + TOF (2 it; 17 ss; filter 2.0/7.0/10.0 mm) or Bayesian-penalized likelihood (Q.Clear; beta, 600/1750/4000). Resulting reconstructed spatial resolution (FWHM) was determined from hot sphere inserts of a NEMA IEC phantom. Data with approx. 5-mm FWHM were retrospectively smoothed to achieve 7-mm FWHM. List mode data were rebinned for acquisition times of 120/90/60 s. Threshold-based delineation of primary tumor MTV was followed by evaluation of relative ASP/SUVmax/MTV differences between datasets and resulting proportions of discordantly classified cases.
Reconstructed resolution for narrow/medium/wide in-plane filter (or low/medium/high beta) was approx. 5/7/9 mm FWHM. Comparing different pairs of reconstructed resolution between TOF, PSF + TOF, Q.Clear and the reference algorithm TOF, ASP differences was lowest at FWHM of 7 versus 7 mm. Proportions of discordant cases (ASP > 19.5% vs. ≤ 19.5%) were also lowest at 7 mm (TOF, 2%; PSF + TOF, 4%; Q.Clear, 10%). Smoothing of 5-mm data to 7-mm FWHM significantly reduced discordant cases (TOF, 38% reduced to 2%; PSF + TOF, 12% to 4%; Q.Clear, 10% to 6%), resulting in proportions comparable to original 7-mm data. Shorter acquisition time only increased proportions of discordant cases at < 90 s.
ASP differences were mainly determined by reconstructed spatial resolution, and multicenter studies should aim at comparable FWHM (e.g., 7 mm; determined by in-plane filter width). This reduces discordant cases (high vs. low ASP) to an acceptable proportion for TOF and PSF + TOF of < 5% (Q.Clear: 10%). Data with better resolution (i.e., lower FWHM) could be retrospectively smoothed to the desired FWHM, resulting in a comparable number of discordant cases.
在非小细胞肺癌(NSCLC)患者中,氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)中原发性肿瘤代谢肿瘤体积(MTV)的非球度(ASP)可独立预测患者的生存率。然而,PET系统之间的可比性可能有限。因此,在不同的图像重建和采集时间评估了ASP的可重复性,以评估在多中心研究中进行ASP评估的可行性。
这是一项对50例NSCLC患者(女性20例;中位年龄69岁)进行的回顾性研究,这些患者接受了治疗前的FDG-PET/CT(中位剂量3.7MBq/kg;每个床位位置180秒)。重建采用带飞行时间(TOF)的有序子集最大期望值算法(OSEM)(迭代次数4;子集16;平面内滤波器2.0、6.4或9.5毫米)、TOF(4次迭代;8个子集;滤波器2.0/6.0/9.5毫米)、点扩散函数(PSF)+TOF(2次迭代;17个子集;滤波器2.0/7.0/10.0毫米)或贝叶斯惩罚似然法(Q.Clear;β值,600/1750/4000)。通过NEMA IEC体模的热球插入物确定最终重建的空间分辨率(半高宽,FWHM)。对约5毫米FWHM的数据进行回顾性平滑处理,以达到7毫米FWHM。对列表模式数据重新分箱,以获得120/90/60秒的采集时间。在基于阈值划定原发性肿瘤MTV之后,评估各数据集之间相对ASP/最大标准摄取值(SUVmax)/MTV的差异以及分类不一致病例的比例。
窄/中/宽平面内滤波器(或低/中/高β值)重建的分辨率约为5/7/9毫米FWHM。比较TOF、PSF+TOF、Q.Clear与参考算法TOF之间不同的重建分辨率对,当FWHM为7对7毫米时,ASP差异最小。不一致病例的比例(ASP>19.5%对≤19.5%)在7毫米时也最低(TOF为2%;PSF+TOF为4%;Q.Clear为10%)。将5毫米数据平滑至7毫米FWHM显著减少了不一致病例(TOF从38%降至2%;PSF+TOF从12%降至4%;Q.Clear从10%降至6%),导致比例与原始7毫米数据相当。较短的采集时间仅在<90秒时增加了不一致病例的比例。
ASP差异主要由重建的空间分辨率决定,多中心研究应旨在获得可比的FWHM(例如7毫米;由平面内滤波器宽度决定)。这将不一致病例(高ASP与低ASP)的比例降低到TOF和PSF+TOF可接受的<5%(Q.Clear为10%)。具有更好分辨率(即更低FWHM)的数据可回顾性平滑至所需的FWHM,从而产生数量相当的不一致病例。